HomeCompareBIOQ vs SBUX

BIOQ vs SBUX: Dividend Comparison 2026

BIOQ yields 1.33% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SBUX wins by $137.3K in total portfolio value
10 years
BIOQ
BIOQ
● Live price
1.33%
Share price
$37.51
Annual div
$0.50
5Y div CAGR
-28.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.2K
Annual income
$4.64
Full BIOQ calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — BIOQ vs SBUX

📍 SBUX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBIOQSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BIOQ + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BIOQ pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BIOQ
Annual income on $10K today (after 15% tax)
$113.30/yr
After 10yr DRIP, annual income (after tax)
$3.94/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, SBUX beats the other by $55,960.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BIOQ + SBUX for your $10,000?

BIOQ: 50%SBUX: 50%
100% SBUX50/50100% BIOQ
Portfolio after 10yr
$88.9K
Annual income
$32,922.38/yr
Blended yield
37.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

BIOQ
No analyst data
Altman Z
2.1
Piotroski
6/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BIOQ buys
0
SBUX buys
0
No recent congressional trades found for BIOQ or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBIOQSBUX
Forward yield1.33%2.75%
Annual dividend / share$0.50$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-28.7%48.3%
Portfolio after 10y$20.2K$157.5K
Annual income after 10y$4.64$65,840.13
Total dividends collected$324.00$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: BIOQ vs SBUX ($10,000, DRIP)

YearBIOQ PortfolioBIOQ Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$10,795$95.04$11,107$407.21$312.00SBUX
2$11,619$68.37$12,512$626.87$893.00SBUX
3$12,481$49.03$14,366$978.69$1.9KSBUX
4$13,390$35.10$16,929$1,557.50$3.5KSBUX
5$14,353$25.09$20,658$2,543.80$6.3KSBUX
6$15,375$17.92$26,406$4,302.22$11.0KSBUX
7$16,464$12.79$35,877$7,622.00$19.4KSBUX
8$17,626$9.13$52,741$14,352.64$35.1KSBUX
9$18,866$6.51$85,676$29,243.03$66.8KSBUX
10$20,192$4.64$157,513$65,840.13$137.3KSBUX

BIOQ vs SBUX: Complete Analysis 2026

BIOQStock

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.

Full BIOQ Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this BIOQ vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BIOQ vs SCHDBIOQ vs JEPIBIOQ vs OBIOQ vs KOBIOQ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.